Biosig announces cost reductions to improve its financial standing and shifts its core strategy

Westport, ct, jan. 30, 2024 (globe newswire) --   biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company committed to delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced a workforce reduction, intended to reduce annual cash burn by 50%.  the company is reducing its internal workforce, which is expected to be completed by january 31. the company is also shifting its business model and seeks to partner with organizations for sales distribution and clinical support of its pure ep™ platform.
BSGM Ratings Summary
BSGM Quant Ranking